Abiopharma

🔍 LO FRANCIS (Executive)

Company: Adaptive Biotechnologies Corp (ADPT)

Report Date: 2026-01-12

Detailed Transactions and Holdings:

• Acquired 36,650 shares of Common Stock at $7.8 per share (Direct)
  Date: 2026-01-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 352,628.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 7,723 shares of Common Stock at $12.14 per share (Direct)
  Date: 2026-01-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 360,351.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 21,002 shares of Common Stock at $8.46 per share (Direct)
  Date: 2026-01-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 381,353.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 14,215 shares of Common Stock at $3.99 per share (Direct)
  Date: 2026-01-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 395,568.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 79,590 shares of Common Stock at $17.73 per share (Direct)
  Date: 2026-01-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 315,978.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-12 | Code: H | nature_of_ownership: By You Jin Lee (spouse) | shares_owned_after: 2,500.00
• Sold 36,650 shares of Stock Option (right to buy) at $7.8 per share (Derivative)
  Date: 2026-01-12 | Code: M | Expires: 2029-05-06 | equity_swap_involved: 0 | shares_owned_after: 75,500.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 7,723 shares of Stock Option (right to buy) at $12.14 per share (Derivative)
  Date: 2026-01-12 | Code: M | Expires: 2032-03-04 | equity_swap_involved: 0 | shares_owned_after: 177,615.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 21,002 shares of Stock Option (right to buy) at $8.46 per share (Derivative)
  Date: 2026-01-12 | Code: M | Expires: 2033-03-06 | equity_swap_involved: 0 | shares_owned_after: 87,074.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 14,215 shares of Stock Option (right to buy) at $3.99 per share (Derivative)
  Date: 2026-01-12 | Code: M | Expires: 2034-03-04 | equity_swap_involved: 0 | shares_owned_after: 90,641.00 | transaction_form_type: 4 | Footnotes: F1, F5

Footnotes:

• F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025.
• F2: The option is fully vested and exercisable.
• F3: The options vested with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
• F4: The options vested with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
• F5: The options vested with respect to 1/4 of such shares on March 4, 2025, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.